Orchard Therapeutics

Orchard Therapeutics

HQ
Boston, MA
196 Total Employees
Year Founded: 2015

Jobs at Similar Companies

Similar Companies Hiring

Software • Pharmaceutical • Machine Learning • Biotech • Big Data • Artificial Intelligence • Analytics
10 Offices
63000 Employees
Software • Healthtech • Hardware • Analytics
New York, NY
25 Employees
Telehealth • Social Impact • Pharmaceutical • Healthtech
Miami, FL
13 Employees

At Orchard Therapeutics, our vision is to end the devastation caused by genetic and other severe diseases. We aim to do this by discovering, developing and commercializing new treatments that tap into the curative potential of hematopoietic stem cell (HSC) gene therapy. In this approach, a patient’s own blood stem cells are genetically modified outside of the body and then reinserted, with the goal of correcting the underlying cause of disease in a single treatment. In 2018, the company acquired GSK’s rare disease gene therapy portfolio, which originated from a pioneering collaboration between GSK and the San Raffaele Telethon Institute for Gene Therapy in Milan, Italy. Today, Orchard is advancing a pipeline spanning pre-clinical, clinical and commercial stage HSC gene therapies designed to address serious diseases where the burden is immense for patients, families and society and current treatment options are limited or do not exist. Orchard has its global headquarters in London and U.S. headquarters in Boston. For more information, please visit www.orchard-tx.com,


Orchard Therapeutics Offices

OnSite Workspace

Employees work from physical offices.

Typical time on-site: None
HQBoston, MA